Summer 2022 Vol. 12 Issue 02
From the Editor-in-Chief
RAS as an ‘Undruggable’ Drug Target
New therapies are being developed to attack a previously untreatable cancer mutation.
by William G. Nelson, MD, PhD
Your Cancer Guide
Marking Cancer Milestones
Find unique ways to honor significant dates as you move forward after cancer treatment.
by Hester Hill Schnipper
Caregiving With Confidence
Learning Your Limits
As a caregiver, you want to be there for your loved ones, but it's also necessary to take time for yourself.
by K.J. Bannan
A Groundbreaking Report on COVID-19 and Cancer
The report released by the American Association for Cancer Research includes a Call to Action that offers a roadmap for policymakers to better prepare and respond to the next pandemic.
by Antoni Ribas, MD, PhD
The Pain of Grief
People affected by cancer often experience intense feelings of loss when those around them die of the disease.
by Charlotte Huff
Comorbidity: Treating the Whole Patient
Patients with cancer often have at least one other chronic disease. Researchers hope to shine a light on how conditions and treatments interact in patients with chronic lymphocytic leukemia and other cancer types.
by Eric Fitzsimmons
Disparities in Cervical Cancer
Many women are being diagnosed with cervical cancer, despite the availability of tools to prevent and diagnose the disease. Black and Hispanic women and low-income and rural populations are especially vulnerable.
by Natalie Slivinski
Control What You Can
Business leader CiCi Rojas takes life lessons from lymphoma.
by Lindsey Konkel Neabore
Show Me You Care
Theresa Brown, who was a nurse when she was diagnosed with breast cancer, writes about deep gaps in her own care.
by Marci A. Landsmann
Blankets of Support
Teenage cancer survivor provides comfort to children with cancer.
by Thomas Celona
Facts and Stats
Driving Down Lung Cancer Deaths
Screenings, treatment advances and declines in smoking have led to a decrease in lung cancer death rates.
by Eric Fitzsimmons
Lesbians, bisexual women and transgender men had a longer wait for diagnosis and a higher risk of recurrence.
by Jon KelveyDeconstructing Peripheral Neuropathy and Chemo Brain
Researchers explore mechanisms of chemotherapy-related neurotoxicity at the AACR Annual Meeting 2023.
by Marci A. LandsmannAACR Annual Meeting 2023
Catch up on all of Cancer Today's coverage from the AACR Annual Meeting 2023.More Prostate Cancer Patients Choose Surveillance
Men are increasingly opting to put off treatment for low-risk prostate cancer, and doctors say it’s a good thing.
by Kyle Bagenstose